Multiple inflammatory and immune pathways

"Multiple inflammatory and immune pathways" refers to a diverse array of molecular and cellular circuits mediating both inflammatory and immunological processes in the body. These pathways involve numerous cell types (such as macrophages, lymphocytes, neutrophils, and dendritic cells) and molecular mediators (including cytokines like TNF-α, IL-6, IL-1β, interferons, chemokines, and growth factors). Pathways such as NF-κB, JAK-STAT, inflammasomes (e.g. NLRP3), and multiple interleukin signaling cascades orchestrate responses to infection, injury, and tissue damage, balancing protection and repair with risks of chronic inflammation and disease. Pharmacologic targeting of inflammatory and immune pathways underlies the development of treatments for autoimmune disorders, allergy, cancer, and many chronic inflammatory conditions, but requires careful modulation due to the complexity and redundancy of immune regulation and the risk of unintended immunosuppression or overactivation. "Multiple inflammatory and immune pathways" is a category, not a singular target. Drug discovery efforts focus on discrete nodes—such as individual cytokines (TNF-α, IL-6, IL-1β, etc.), kinases (JAKs), or cellular receptors—each of which constitutes a specific, actionable therapeutic target. Entry of this term as a "target" is considered **incorrect** for structured databases that require individual molecule/receptor names.

Other names

inflammatory pathwaysimmune signaling pathwayspro-inflammatory pathwaysimmune axescytokine signalinginflammation cascadesimmune pathways

Cytokine inhibition (e.g. TNF-α, IL-6 inhibitors); Immunosuppression (e.g. calcineurin inhibition); Modulation of cell signaling (e.g. JAK-STAT pathway inhibitors); Anti-inflammatory mechanisms (e.g. corticosteroids); Disease-modifying effects (e.g. antirheumatic drugs)